牛叉诊股

[{"date":"2026.05.28","stock":"-0.69","trade":"-0.71","ind":"0.80"},{"date":"2026.05.27","stock":"-2.96","trade":"-1.05","ind":"-0.88"},{"date":"2026.05.26","stock":"-3.43","trade":"-1.43","ind":"0.12"},{"date":"2026.05.25","stock":"-2.58","trade":"-1.35","ind":"1.66"},{"date":"2026.05.22","stock":"2.06","trade":"0.11","ind":"2.30"},{"date":"2026.05.21","stock":"-4.03","trade":"-1.67","ind":"-2.07"},{"date":"2026.05.20","stock":"-1.55","trade":"-0.92","ind":"0.00"},{"date":"2026.05.19","stock":"0.68","trade":"0.64","ind":"0.26"},{"date":"2026.05.18","stock":"-1.20","trade":"-1.49","ind":"-0.20"},{"date":"2026.05.15","stock":"-2.60","trade":"-0.71","ind":"-1.17"},{"date":"2026.05.14","stock":"-0.32","trade":"-1.71","ind":"-2.14"},{"date":"2026.05.13","stock":"-0.06","trade":"-0.44","ind":"1.67"},{"date":"2026.05.12","stock":"-2.65","trade":"-1.41","ind":"-0.47"},{"date":"2026.05.11","stock":"1.73","trade":"1.65","ind":"2.16"},{"date":"2026.05.08","stock":"1.76","trade":"0.14","ind":"-0.50"},{"date":"2026.05.07","stock":"0.66","trade":"-0.07","ind":"1.18"},{"date":"2026.05.06","stock":"0.53","trade":"0.78","ind":"2.33"},{"date":"2026.04.30","stock":"1.96","trade":"0.52","ind":"-0.09"},{"date":"2026.04.29","stock":"3.34","trade":"0.65","ind":"1.96"},{"date":"2026.04.28","stock":"2.14","trade":"-0.61","ind":"-1.10"},{"date":"2026.04.27","stock":"1.89","trade":"0.54","ind":"0.37"}]

赛托生物,深证成指,化学制药指数

压力支撑

该股压力位为12.89元，支撑位为12.57元。

[{"text":"\u538b\u529b\u4f4d","value":"12.89","date":1779897600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.57","date":1779897600,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.1资金面打败了84%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：05月28日 20:30

机构今日流向(万元)	-1960.37	机构5日流向(万元)	-7121.88
机构10日流向(万元)	-16990.76	机构20日流向(万元)	-27647.73

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加199.72万股，其中基金净增仓3家，主力净增仓15家，有一定的中长期投资价值。

截止2025-12-31，共48家主力机构（基金47家，一般法人1家），持仓量总计4621.92万股，占流通A股24.83%
其中，基金持仓与2025-06-30相比：
增仓：8家，增持 10.32万股
减仓：5家，减持 11.84万股
新出现在主力名单中：32家，持有228.96万股
从主力名单中消失：17家，原持有27.72万股

消息面诊股

诊断结果：6.7消息面打败了78%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-05-12
利好	分红转增	10派0.05元(含税)	2026-04-28
利好	业绩预告	预计减亏	2026-01-30
一般消息	重大事项	关联交易	2026-01-16
一般消息	重大事项	公司股东股份解押	2025-12-26
一般消息	高管变动	任职工董事	2025-09-12
利好	分红转增	10派0.1元(含税)	2025-08-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：1.3行业面打败了16%的股票化学制药行业最新资金流向

近10日来该行业走势总体向下，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，明显跑输大盘。

[{"date":"2026.05.28","price":"0.80","value":"-0.71"},{"date":"2026.05.27","price":"-0.88","value":"-1.05"},{"date":"2026.05.26","price":"0.12","value":"-1.43"},{"date":"2026.05.25","price":"1.66","value":"-1.35"},{"date":"2026.05.22","price":"2.30","value":"0.11"},{"date":"2026.05.21","price":"-2.07","value":"-1.67"},{"date":"2026.05.20","price":"0.00","value":"-0.92"},{"date":"2026.05.19","price":"0.26","value":"0.64"},{"date":"2026.05.18","price":"-0.20","value":"-1.49"},{"date":"2026.05.15","price":"-1.17","value":"-0.71"},{"date":"2026.05.14","price":"-2.14","value":"-1.71"},{"date":"2026.05.13","price":"1.67","value":"-0.44"},{"date":"2026.05.12","price":"-0.47","value":"-1.41"},{"date":"2026.05.11","price":"2.16","value":"1.65"},{"date":"2026.05.08","price":"-0.50","value":"0.14"},{"date":"2026.05.07","price":"1.18","value":"-0.07"},{"date":"2026.05.06","price":"2.33","value":"0.78"},{"date":"2026.04.30","price":"-0.09","value":"0.52"},{"date":"2026.04.29","price":"1.96","value":"0.65"},{"date":"2026.04.28","price":"-1.10","value":"-0.61"},{"date":"2026.04.27","price":"0.37","value":"0.54"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	宏源药业	27.26%	-0.37%	5.6分
2	纳微科技	23.02%	17.56%	5.8分
3	共同药业	15.63%	2.86%	5.6分
4	南新制药	13.67%	-7.29%	4.2分
5	科源制药	10.88%	14.96%	5.9分
6	翰宇药业	8.75%	7.03%	6.0分
7	ST天圣	6.98%	5.34%	5.0分
8	科伦药业	6.87%	8.12%	5.3分
9	溢多利	6.41%	-5.01%	5.1分
10	一品红	6.11%	2.09%	4.6分
11	华海药业	1.90%	-5.52%	4.6分
12	东亚药业	1.36%	-3.05%	4.9分
13	ST景峰	1.27%	-1.10%	5.2分
14	ST诺泰	1.12%	-2.82%	4.8分
15	中哲精化	0.88%	1.93%	5.7分
16	广生堂	0.29%	-13.22%	4.5分
17	通化金马	0.13%	0.52%	4.8分
18	威尔药业	-0.42%	-2.18%	5.3分
19	百济神州	-0.74%	-7.43%	4.8分
20	贝达药业	-1.64%	-2.03%	4.7分
21	常山药业	-2.11%	-3.90%	4.1分
22	昂利康	-2.28%	-22.23%	4.9分
23	ST复华	-2.30%	-6.59%	4.6分
24	灵康药业	-2.34%	-2.11%	4.3分
25	必贝特	-2.35%	-7.75%	5.5分
26	奥赛康	-2.76%	-15.91%	4.7分
27	奥翔药业	-2.76%	-4.73%	4.7分
28	泽璟制药	-3.20%	-6.15%	4.1分
29	海创药业	-3.29%	-8.34%	4.0分
30	尔康制药	-3.45%	-7.55%	4.4分
31	艾力斯	-3.49%	-5.99%	4.4分
32	迪哲医药	-3.51%	-5.79%	4.0分
33	鲁抗医药	-3.59%	-3.95%	4.7分
34	赛分科技	-4.33%	-0.26%	4.8分
35	多瑞医药	-4.44%	-9.32%	4.5分
36	-	-4.44%	-3.79%	分
37	花园生物	-4.45%	-2.58%	4.0分
38	-	-4.48%	-1.57%	分
39	仙琚制药	-4.73%	-1.55%	5.0分
40	华特达因	-4.91%	-3.95%	4.1分
41	首药控股	-5.06%	-13.36%	3.7分
42	仟源医药	-5.15%	-10.63%	4.7分
43	上海谊众	-5.15%	-6.16%	4.1分
44	诚意药业	-5.37%	1.99%	4.7分
45	东诚药业	-5.42%	-1.18%	5.2分
46	哈三联	-5.50%	-4.10%	5.0分
47	西点药业	-5.52%	-5.92%	4.4分
48	海欣股份	-5.58%	8.31%	4.5分
49	国药现代	-5.63%	-0.66%	4.3分
50	宣泰医药	-5.90%	-3.69%	3.9分
51	复旦张江	-6.27%	-4.44%	3.8分
52	-	-6.34%	-4.19%	分
53	康芝药业	-6.36%	-4.61%	4.4分
54	ST人福	-6.51%	-3.07%	4.2分
55	亿帆医药	-7.33%	-0.10%	4.4分
56	广济药业	-7.35%	-4.62%	4.9分
57	新华制药	-7.36%	-6.17%	4.5分
58	赛托生物	-7.40%	-7.47%	5.4分
59	华润双鹤	-7.41%	-3.62%	4.2分
60	微芯生物	-7.44%	-4.13%	4.1分
61	悦康药业	-7.60%	-3.28%	3.9分
62	德展健康	-7.63%	-14.17%	4.3分
63	富士莱	-7.64%	-6.23%	4.9分
64	九典制药	-7.75%	2.39%	4.3分
65	恩华药业	-7.79%	-1.08%	4.4分
66	福安药业	-7.79%	-1.30%	4.3分
67	丽珠集团	-7.81%	-3.26%	4.3分
68	川宁生物	-7.96%	-3.58%	4.5分
69	东北制药	-8.02%	-5.36%	4.3分
70	-	-8.13%	-2.68%	分
71	天新药业	-8.34%	-2.54%	3.9分
72	易明医药	-8.50%	1.52%	5.3分
73	-	-8.56%	-4.64%	分
74	前沿生物	-8.58%	-5.50%	4.8分
75	中关村	-8.72%	-1.61%	4.8分
76	司太立	-8.94%	-16.99%	4.4分
77	健康元	-9.01%	-2.65%	4.2分
78	国邦医药	-9.14%	-1.71%	3.8分
79	华邦健康	-9.29%	-3.44%	4.2分
80	圣诺生物	-9.34%	-1.92%	4.3分
81	华仁药业	-9.68%	-2.78%	4.6分
82	本立科技	-9.73%	-3.73%	4.7分
83	汇宇制药	-10.01%	-13.28%	3.9分
84	丰原药业	-10.28%	-4.55%	4.4分
85	津药药业	-10.32%	-10.95%	4.7分
86	复星医药	-10.33%	-4.05%	4.1分
87	海普瑞	-10.41%	-4.61%	4.5分
88	永安药业	-10.49%	-3.84%	4.7分
89	ST惠程	-10.65%	-1.53%	4.6分
90	神奇制药	-10.88%	-3.19%	5.4分
91	山河药辅	-10.89%	-1.56%	4.4分
92	哈药股份	-10.90%	-2.39%	4.1分
93	亚虹医药	-10.90%	-6.72%	4.1分
94	新和成	-10.91%	0.70%	4.5分
95	辰欣药业	-10.92%	-3.92%	3.7分
96	普洛药业	-10.94%	-2.71%	5.0分
97	拓新药业	-11.11%	-7.81%	3.5分
98	北陆药业	-11.32%	-2.92%	4.5分
99	三圣股份	-11.51%	-4.30%	4.4分
100	天宇股份	-11.55%	0.00%	4.7分
101	民生健康	-11.58%	-5.45%	4.6分
102	莎普爱思	-11.61%	-4.25%	4.0分
103	向日葵	-11.66%	-5.28%	4.1分
104	-	-11.69%	-3.77%	分
105	-	-12.09%	-7.35%	分
106	新天地	-12.25%	-5.23%	4.3分
107	-	-12.32%	-4.35%	分
108	千红制药	-12.40%	-2.78%	4.5分
109	亚太药业	-12.46%	-2.48%	3.9分
110	莱美药业	-12.54%	-4.12%	4.1分
111	京新药业	-12.62%	-6.51%	4.5分
112	亨迪药业	-12.69%	-5.16%	4.6分
113	福元医药	-12.70%	-3.24%	4.1分
114	华纳药厂	-12.83%	-5.17%	4.2分
115	泰恩康	-12.90%	-3.97%	4.5分
116	海正药业	-12.96%	-4.97%	4.4分
117	恒瑞医药	-13.01%	-6.34%	4.3分
118	卫信康	-13.10%	-3.86%	4.1分
119	浙江医药	-13.60%	-7.91%	4.2分
120	汉商集团	-13.60%	-4.55%	4.3分
121	润都股份	-13.64%	-7.04%	5.2分
122	吉贝尔	-13.76%	-4.54%	4.1分
123	金陵药业	-13.87%	-3.54%	4.8分
124	海思科	-14.06%	-3.22%	5.4分
125	同和药业	-14.07%	-2.13%	4.6分
126	华北制药	-14.18%	-6.08%	3.7分
127	舒泰神	-14.25%	-10.37%	3.8分
128	北大医药	-14.65%	-2.93%	4.2分
129	金石亚药	-14.67%	-7.10%	4.6分
130	联环药业	-14.88%	-9.09%	4.0分
131	博瑞医药	-14.88%	-8.76%	4.0分
132	健友股份	-14.93%	-3.86%	3.9分
133	立方制药	-15.41%	-4.18%	4.9分
134	双鹭药业	-15.43%	-4.28%	4.3分
135	-	-15.45%	-4.51%	分
136	华东医药	-15.76%	-2.77%	4.3分
137	凯因科技	-16.06%	-6.25%	3.9分
138	小方制药	-16.23%	-6.74%	4.1分
139	力生制药	-16.42%	-2.59%	4.6分
140	奥锐特	-16.89%	-8.65%	4.4分
141	新诺威	-16.99%	-9.33%	3.8分
142	金城医药	-17.28%	-10.70%	5.2分
143	益方生物	-17.65%	-8.70%	3.5分
144	海森药业	-18.87%	-5.95%	4.0分
145	美诺华	-19.33%	-14.39%	4.4分
146	海辰药业	-19.44%	-5.93%	4.8分
147	海南海药	-20.23%	-3.98%	4.2分
148	罗欣药业	-20.48%	-6.15%	5.1分
149	兴齐眼药	-20.70%	-11.84%	4.0分
150	ST能特	-21.07%	-5.56%	4.4分
151	富祥股份	-21.48%	-2.39%	4.7分
152	誉衡药业	-21.49%	-3.27%	5.1分
153	盟科药业	-21.78%	-6.32%	3.9分
154	苑东生物	-21.97%	-7.66%	4.0分
155	百利天恒	-22.82%	-12.20%	3.2分
156	海翔药业	-24.97%	-2.70%	4.8分
157	键凯科技	-27.00%	-5.55%	4.2分
158	*ST赛隆	-28.14%	-22.65%	4.0分
159	信立泰	-39.89%	-8.98%	4.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.9基本面打败了50%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（80分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 116/218 ， 136/218。

[{"date":"2026-03-31","value":"0.20","vol":"0.43"},{"date":"2025-12-31","value":"-4.06","vol":"-2.03"},{"date":"2025-09-30","value":"-3.84","vol":"1.53"},{"date":"2025-06-30","value":"-2.91","vol":"1.24"},{"date":"2025-03-31","value":"-1.51","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	0.20	-4.06	-3.84	-2.91	-1.51
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"22.08","vol":"50.72"},{"date":"2025-12-31","value":"15.00","vol":"49.72"},{"date":"2025-09-30","value":"12.53","vol":"49.60"},{"date":"2025-06-30","value":"12.01","vol":"49.57"},{"date":"2025-03-31","value":"8.94","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	22.08	15.00	12.53	12.01	8.94
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 27/218 ， 22/218。

[{"date":"2026-03-31","value":"26.24","vol":"25.51"},{"date":"2025-12-31","value":"4.77","vol":"38.97"},{"date":"2025-09-30","value":"-2.07","vol":"141.63"},{"date":"2025-06-30","value":"-10.39","vol":"78.56"},{"date":"2025-03-31","value":"6.32","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	26.24	4.77	-2.07	-10.39	6.32
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"113.15","vol":"47.13"},{"date":"2025-12-31","value":"17.60","vol":"-26.11"},{"date":"2025-09-30","value":"-570.46","vol":"-2.93"},{"date":"2025-06-30","value":"-498.80","vol":"59.61"},{"date":"2025-03-31","value":"-995.83","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	113.15	17.60	-570.46	-498.80	-995.83
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 66/218 ， 66/218。

[{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.34","vol":"0.41"},{"date":"2025-09-30","value":"0.25","vol":"0.31"},{"date":"2025-06-30","value":"0.17","vol":"0.21"},{"date":"2025-03-31","value":"0.09","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.11	0.34	0.25	0.17	0.09
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.59","vol":"0.65"},{"date":"2025-12-31","value":"1.54","vol":"2.58"},{"date":"2025-09-30","value":"1.15","vol":"1.93"},{"date":"2025-06-30","value":"0.77","vol":"1.29"},{"date":"2025-03-31","value":"0.40","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.59	1.54	1.15	0.77	0.40
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"9.37","vol":"-2.81"},{"date":"2025-12-31","value":"30.16","vol":"16.49"},{"date":"2025-09-30","value":"6.27","vol":"4.26"},{"date":"2025-06-30","value":"29.43","vol":"2.95"},{"date":"2025-03-31","value":"-3.95","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	9.37	30.16	6.27	29.43	-3.95
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.47","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.47	-	0.29	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 54/218 ， 14/218。

[{"date":"2026-03-31","value":"1.27","vol":"3.57"},{"date":"2025-12-31","value":"1.28","vol":"3.31"},{"date":"2025-09-30","value":"1.21","vol":"3.48"},{"date":"2025-06-30","value":"1.23","vol":"3.66"},{"date":"2025-03-31","value":"1.25","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.27	1.28	1.21	1.23	1.25
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.84","vol":"2.93"},{"date":"2025-12-31","value":"0.78","vol":"2.69"},{"date":"2025-09-30","value":"0.69","vol":"2.73"},{"date":"2025-06-30","value":"0.69","vol":"2.88"},{"date":"2025-03-31","value":"0.65","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.84	0.78	0.69	0.69	0.65
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/218 ， 57/218。

[{"date":"2026-03-31","value":"38.56","vol":"33.54"},{"date":"2025-12-31","value":"39.21","vol":"34.70"},{"date":"2025-09-30","value":"37.15","vol":"34.06"},{"date":"2025-06-30","value":"37.66","vol":"34.12"},{"date":"2025-03-31","value":"36.92","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	38.56	39.21	37.15	37.66	36.92
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.64","vol":"9.77"},{"date":"2025-12-31","value":"0.66","vol":"1.76"},{"date":"2025-09-30","value":"0.60","vol":"1.19"},{"date":"2025-06-30","value":"0.62","vol":"0.87"},{"date":"2025-03-31","value":"0.60","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.64	0.66	0.60	0.62	0.60
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.46","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.89","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[赛托生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]